Prevalence and incidence of polymyositis and dermatomyositis in Japan

Modern Rheumatology

Volumn 24, Issue 3, 2014, Pages 477-480

  Ohta, Akiko ^a   Nagai, Masaki ^a   Nishina, Motoko ^a   Tomimitsu, Hiroyuki ^b   Kohsaka, Hitoshi ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Epidemiology; Incidence; Nationwide survey; Polymyositis dermatomyositis (PM DM); Prevalence

Indexed keywords

ARTICLE; DATA BASE; DERMATOMYOSITIS; DISEASE REGISTRY; HEALTH SURVEY; HUMAN; INCIDENCE; JAPAN; POLYMYOSITIS; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; EPIDEMIOLOGY; FACTUAL DATABASE;

DATABASES, FACTUAL; DERMATOMYOSITIS; HUMANS; INCIDENCE; JAPAN; POLYMYOSITIS; PREVALENCE;

EID: 84900405275     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/14397595.2013.844308     Document Type: Article

References (16)

1. Oddis CV Ascherman DP. Clinical features classification and epidemiology of inflammatory muscle disease. In: Hochberg MC Silman AJ Smolen JS Weinblatt ME Weisman MH editors. Rheumatology. 5th Ed. Philadelphia: Mosby/Elsevier; 2010. pp. 1439-40
2. Mastaglia FL Phillips BA. Idiopathic inflammatory myopathies: Epidemiology classification and diagnostic criteria. Rheum Dis Clin N Am. 2002;28(4):723-41
3. Cox S Limaye V Hill C Blumbergs P Roberts-Thomson P. Idiopathic inflammatory myopathies: Diagnostic criteria classification and epidemiological features. Int J Rheum Dis. 2010;13(2): 117-24
4. Kurland LT Hauser WA Ferguson RH Holley KE. Epidemiologic features of diffuse connective tissue disorders in Rochester Minn. 1951 through 1967 with special reference to systemic lupus erythematosus. Mayo Clin Proc. 1969;44(9):649-93
5. Medsger TA Jr Dawson WN Jr Masi AT. The epidemiology of polymyositis. Am J Med. 1970;48(6):715-23
6. Benbassat J Geffel D Zlotnick A. Epidemiology of polymyositisdermatomyositis in Israel 1960-76. Isr J Med Sci. 1980;16(3): 197-200
7. Oddis CV Conte CG Steen VD Medsger TA Jr. Incidence of polymyositis-dermatomyositis: 20-year study of hospital diagnosed cases in Allegheny County PA 1963-1982. JRheumatol. 1990;17(10):1329-34
8. Weitoft T. Occurrence of polymyositis in the county of G̈vleborg Sweden. Scand J Rheumatol. 1997;26(2):104-6
9. Patrick M Buchbinder R Jolley D Dennett X Buchanan R. Incidence of inflammatory myopathies in Victoria Australia and evidence of spatial clustering. JRheumatol. 1999;26(5):1094-100
10. Koh ET Seow A Ong B Ratnagopal P Tjia H Chng HH. Adult onset polymyositis/dermatomyositis: Clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis. 1993;52(12):857-61
11. Kusumi M Nakashima K Nakayama H Takahashi K. Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tottori Prefecture Japan. Psychiatry Clin Neurosci. 1995;49(3):169-74
12. Araki S Uchino M Kumamoto T. Prevalence studies of multiple sclerosis myasthenia gravis and myopathies in Kumamoto district Japan. Neuroepidemiology. 1987;6(3):120-9
13. Tamakoshi A Ohno Y Sasaki R Kubo N Hashimoto S Nakamura T et al. Estimation of the number of patients with intractable diseases from a nationwide epidemiologic survey (in Japanese). Nihon Iji Shinpo. 1993;(3601);49-52
14. Hayashi S Umeda T. 35 years of Japanese policy on rare diseases. Lancet. 2008;372(9642):889-90
15. Tanimoto K Nakano K Kano S Mori S Ueki H Nishitani H et al. Classification criteria for polymyositis and dermatomyositis. J Rheumatol. 1995;22(4):668-74
16. Statistics and Information Department Ministers Secretariat Ministry of Health Labour and Welfare. Report on Public Health Administration and Services 2003-2010 (in Japanese). Tokyo: Statistics and Information Department Ministry of Health Labour and Welfare Japan. 2005-2012